E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/5/2005 in the Prospect News Biotech Daily.

SeraCare expands revolver to $25 million

By E. Janene Geiss

Philadelphia, Oct. 5 - SeraCare Life Sciences, Inc. announced Wednesday an expansion of its credit facility with its existing banks.

The Oceanside, Calif.-based company said it amended its aggregate revolving loan commitment to $25 million from $10 million with Brown Brothers Harriman & Co. and Union Bank of California, NA. The amendment also adds a $2 million swing line facility, company officials said.

The company said it plans to use the financing to further growth internally and through possible acquisitions. SeraCare is a manufacturer and supplier of biological materials used with diagnostic tests and develops and produces pharmaceuticals.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.